The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study by Yonemori, Kan, Shimizu, Toshio, Kondo, Shunsuke, Iwasa, Satoru, Koyama, Takafumi, Kitano, Shigehisa, Sato, Jun, Shimomura, Akihiko, Shibaki, Ryota, Suri, Ajit, Kase, Yoichi, Sumino, Shuuji, Tamura, Kenji, Yamamoto, Noboru

Get full text

Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive bre... by Kurebayashi, Junichi, Toyama, Tatsuya, Sumino, Shuuji, Miyajima, Eri, Fujimoto, Tsukasa

Get full text

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer by Takehara, Kazuhiro, Matsumoto, Takashi, Hamanishi, Junzo, Hasegawa, Kosei, Matsuura, Motoki, Miura, Kiyonori, Nagao, Shoji, Nakai, Hidekatsu, Tanaka, Naotake, Tokunaga, Hideki, Ushijima, Kimio, Watari, Hidemichi, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Suri, Ajit, Itamochi, Hiroaki, Takeshima, Nobuhiro

Get full text

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer by Okamoto, Aikou, Kondo, Eiji, Nakamura, Toshiaki, Yanagida, Satoshi, Hamanishi, Junzo, Harano, Kenichi, Hasegawa, Kosei, Hirasawa, Takeshi, Hori, Kensuke, Komiyama, Shinichi, Matsuura, Motoki, Nakai, Hidekatsu, Nakamura, Hiroko, Sakata, Jun, Tabata, Tsutomu, Takehara, Kazuhiro, Takekuma, Munetaka, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Soeda, Junpei, Suri, Ajit, Aoki, Daisuke, Sugiyama, Toru

Get full text

Randomized, double‐blind, phase III study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 d... by Kaku, Kohei, Sumino, Shuuji, Katou, Masafumi, Nishiyama, Yuya, Kinugawa, Yoshinobu

Get full text

Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study by Itamochi, Hiroaki, Takeshima, Nobuhiro, Hamanishi, Junzo, Hasegawa, Kosei, Matsuura, Motoki, Miura, Kiyonori, Nagao, Shoji, Nakai, Hidekatsu, Tanaka, Naotake, Tokunaga, Hideki, Nishio, Shin, Watari, Hidemichi, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Kato, Ai, Suri, Ajit, Yasuoka, Toshiaki, Takehara, Kazuhiro

Get full text

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study by Aoki, Daisuke, Tabata, Tsutomu, Yanagida, Satoshi, Nakamura, Toshiaki, Kondo, Eiji, Hamanishi, Junzo, Harano, Kenichi, Hasegawa, Kosei, Hirasawa, Takeshi, Hori, Kensuke, Komiyama, Shinichi, Matsuura, Motoki, Nakai, Hidekatsu, Nakamura, Hiroko, Sakata, Jun, Takehara, Kazuhiro, Takekuma, Munetaka, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Soeda, Junpei, Kato, Ai, Suri, Ajit, Okamoto, Aikou, Sugiyama, Toru

Get full text

Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study by Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Shin Nishio, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ai Kato, Ajit Suri, Toshiaki Yasuoka, Kazuhiro Takehara

Get full text

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study by Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Eiji Kondo, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ai Kato, Ajit Suri, Aikou Okamoto, Toru Sugiyama

Get full text

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer by Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Kimio Ushijima, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ajit Suri, Hiroaki Itamochi, Nobuhiro Takeshima

Get full text

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer by Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Tsutomu Tabata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ajit Suri, Daisuke Aoki, Toru Sugiyama

Get full text